Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)

Share :
Published: 28 Jan 2010
Views: 8595
Rating:
Save
Dr Rowan Chlebowski - Harbor-University of California, Los Angeles
Oral bisphosphonates directly inhibit breast cancer incidence. Official San Antonio Breast Cancer Symposium press conference.

Watch Dr Chlebowski presenting his research into oestrogen and progestin therapy at the ASCO 2009 press conference.